share_log

派林生物:2023年度就补偿期限届满对购买资产减值测试的专项审核意见

Pacific Shuanglin Bio-pharmacy: 2023 Special Audit Opinions on Impairment Tests for Purchased Assets on the Expiration of the Compensation Period

Sensex a share ·  Apr 26
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more